ENLV icon

Enlivex Therapeutics

19 hedge funds and large institutions have $795K invested in Enlivex Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

36% less capital invested

Capital invested by funds: $1.24M → $795K (-$443K)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$172K
Puts
$27K
Net Calls
Net Calls Change

Top Buyers

1 +$9.7K
2 +$6.07K
3 +$5.26K
4
AAP
Arax Advisory Partners
Colorado
+$762
Name Holding Trade Value Shares
Change
Change in
Stake
1
$171K
2
$149K
3
$115K
4
$102K
5
$46.8K
6
$39.7K
7
$34.2K
8
$33K
9
$29.7K
10
$27.4K
11
$23.3K
12
$7.88K
13
$6.26K
14
$3K
15
$2.89K
16
$2.2K
17
$1.05K
18
$762
19
$394
20